FOLH1 and cancer: While the biological function of PSMA is not well-defined, increased PSMA expression—typically detected via immunohistochemistry (IHC)—correlates with cancer aggressiveness in localized prostate cancer and has been reported as an independent predictor of poor prognosis in some5–7 but not all studies.8